Olema Pharmaceuticals GAAP EPS of -$0.51 misses by $0.08

2 hours ago 1

Olema Pharmaceuticals press release (NASDAQ:OLMA): Q2 GAAP EPS of -$0.51 misses by $0.08.
Cash, cash equivalents, and marketable securities of $361.9 million as of June 30, 2025.

Recommended For You